Public Profile

Derma Sciences, Inc.

Derma Sciences, Inc., a prominent player in the wound care and advanced medical device industry, is headquartered in the United States. Founded in 1984, the company has established itself as a leader in innovative solutions for wound management, particularly through its advanced dressings and regenerative medicine products. With a focus on enhancing patient outcomes, Derma Sciences offers a range of unique products, including their proprietary MEDIHONEY® line, which harnesses the natural healing properties of honey. The company has achieved significant milestones, including strategic partnerships and a robust presence in both domestic and international markets. Recognised for its commitment to quality and innovation, Derma Sciences continues to set industry standards, making it a trusted name among healthcare professionals and patients alike.

DitchCarbon Score

How does Derma Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Derma Sciences, Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Derma Sciences, Inc.'s reported carbon emissions

Derma Sciences, Inc., headquartered in the US, currently does not have available carbon emissions data or specific reduction targets. Without documented emissions figures or commitments to climate initiatives, it is unclear how the company is addressing its carbon footprint. In the context of the industry, many companies are increasingly focusing on sustainability and setting science-based targets to reduce greenhouse gas emissions. However, as of now, Derma Sciences has not publicly outlined any specific climate commitments or reduction strategies.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Derma Sciences, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Derma Sciences, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Derma Sciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Lineage Cell Therapeutics, Inc.

US
Health and social work services (85)
Updated 1 day ago

Axogen

US
Other business services (74)
Updated 1 day ago

Orthofix

US
Medical, precision and optical instruments, watches and clocks (33)
Updated about 1 hour ago

Acelity L.P. Inc.

US
Health and social work services (85)
Updated 1 day ago

Xtant Medical Holdings, Inc.

US
Health and social work services (85)
Updated 1 day ago

Longeveron Inc.

US
Health and social work services (85)
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers